Amgen Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin

Amgen Inc.’s own tally for this item (“Elect Director: Dr. Wanda M. Austin”): 408,261,366 for, 4,136,960 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 198,059,229 for, 3,785 against, 33,259 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway

Amgen Inc.’s own tally for this item (“Elect Director: Mr. Robert A. Bradway”): 390,137,618 for, 20,492,559 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 198,050,128 for, 12,889 against, 33,260 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake

Amgen Inc.’s own tally for this item (“Elect Director: Dr. Michael V. Drake”): 407,302,029 for, 4,797,875 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 197,776,667 for, 286,344 against, 33,262 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker

Amgen Inc.’s own tally for this item (“Elect Director: Dr. Brian J. Druker”): 409,304,364 for, 3,054,075 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 198,059,246 for, 3,767 against, 33,260 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert

Amgen Inc.’s own tally for this item (“Elect Director: Mr. Robert A. Eckert”): 393,137,908 for, 19,206,011 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 196,963,055 for, 1,099,961 against, 33,260 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland

Amgen Inc.’s own tally for this item (“Elect Director: Mr. Greg C. Garland”): 390,923,223 for, 21,425,903 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 197,085,691 for, 1,175,324 against, 33,260 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.

Amgen Inc.’s own tally for this item (“Elect Director: Mr. Charles M. Holley, Jr.”): 402,699,984 for, 9,642,231 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 197,965,910 for, 295,106 against, 33,260 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak

Amgen Inc.’s own tally for this item (“Elect Director: Dr. S. Omar Ishrak”): 408,204,077 for, 4,139,152 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 198,251,416 for, 9,597 against, 33,260 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks

Amgen Inc.’s own tally for this item (“Elect Director: Dr. Tyler Jacks”): 400,237,518 for, 12,117,252 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 197,487,829 for, 773,185 against, 33,260 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman

Amgen Inc.’s own tally for this item (“Elect Director: Dr. Mary E. Klotman”): 407,732,503 for, 4,398,737 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 197,980,485 for, 280,525 against, 33,262 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman

Amgen Inc.’s own tally for this item (“Elect Director: Ms. Ellen J. Kullman”): 405,340,175 for, 6,775,403 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 197,211,263 for, 1,049,747 against, 33,262 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles

Amgen Inc.’s own tally for this item (“Elect Director: Ms. Amy E. Miles”): 406,709,817 for, 5,385,886 against, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2027 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 197,770,128 for, 300,882 against, 33,262 abstained, 455 not voted, 10,234 unknown.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: Advisory vote to approve our executive compensation.

Amgen Inc.’s own tally for this item (“2. Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation”): 399,315,381 for, 11,987,682 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 2 - Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation was approved.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 223 managers: 197,520,804 for, 65,648 against, 33,277 abstained, 459 not voted, 6,938 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1,322 managers: 243,672,892 for, 5,972,552 against, 24,483 abstained, 115,467 not voted, 47,912 mixed, 3,296 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026.

Amgen Inc.’s own tally for this item (“3. Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP”): 447,904,443 for, 28,209,748 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 3 - Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP was ratified as the Company's independent registered public accountants for the fiscal year ending December 31, 2026.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Amgen Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (8 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 240 asset managers below reported 196,856,035 for, 886,628 against, 33,256 abstained, 455 not voted, 6,938 unknown.

Showing the 25 largest of 240 asset managers. See all 240 in the interactive database.

Description as filed by funds: Stockholder proposal to require an independent board chairman.

Amgen Inc.’s own tally for this item (“4. Stockholder Proposal to Require an Independent Board Chairman The stockholder proposal to require an independent board chairman”): 72,902,413 for, 338,465,655 against — failed, per its Form 8-K filed May 20, 2026 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “Item 4 - Stockholder Proposal to Require an Independent Board Chairman The stockholder proposal to require an independent board chairman was not approved.”
Support: 18% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Amgen Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Shareholder Proposal Regarding Independent Chair” (3 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 246 asset managers below reported 5,670,500 for, 192,114,594 against, 33,273 abstained, 455 not voted, 8,235 unknown.

Showing the 25 largest of 246 asset managers. See all 246 in the interactive database.